Metabolic Syndrome is a common condition whose prevalence is rising to epidemic proportions, having a significant impact on public health and the global economy.
Hypertension has been identified by WHO as one of the most significant risk factors for morbidity and mortality worldwide and is responsible for the deaths of approximately nine million people annually.
Ischaemic heart disease (e.g. coronary artery disease) is responsible for almost half of all cardiovascular deaths with around 30% of all deaths worldwide in cardiovascular diseases.
The Cardiovascular Health Study estimated CHF incidence as 19.3 per 1000 person-years in those aged >65 years.
Chronic heart failure (CHF) is a clinical syndrome frequently accompanied by a high load of co-morbidities and characterized by poor outcomes, despite the provision of optimal medical guideline-directed treatments.
